Macrolide-resistant Mycoplasma pneumoniae: Characteristics of isolates and clinical aspects of community-acquired pneumonia

Journal of Infection and Chemotherapy

Volumn 16, Issue 2, 2010, Pages 78-86

  Morozumi, Miyuki ^a   Takahashi, Takashi ^a   Ubukata, Kimiko ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Clinical features; Community acquired pneumonia; Macrolide resistance; Mechanisms of antimicrobial resistance; Mycoplasma pneumoniae; Real time PCR

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; GARENOXACIN; JOSAMYCIN; KETOLIDE; LEVOFLOXACIN; MACROLIDE; MIDECAMYCIN; MINOCYCLINE; MOXIFLOXACIN; PAZUFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA 23S; ROKITAMYCIN; SITAFLOXACIN; STEROID; TELITHROMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL MUTATION; BACTERIUM ISOLATION; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DRUG BINDING SITE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; JAPAN; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; STEROID THERAPY; STRAIN DIFFERENCE;

EID: 77952243582     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-009-0021-4     Document Type: Review

References (97)

1. Waites KB, Rikihisa Y, Taylor-Robinson D. Mycoplasma, Ureaplasma. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of clinical microbiology. 8th edn. Washington: American Society for Microbiology; 2003. p. 972-90.
2. MR Hammerschlag 2001 Mycoplasma pneumoniae infections Curr Opin Infect Dis 14 181 186 10.1097/00001432-200104000-00012 1:STN:280:DC%2BD383ktVSisw%3D%3D 11979130
3. T Heiskanen-Kosma M Korppi C Jokinen S Kurki L Heiskanen H Juvonen, et al. 1998 Etiology of childhood pneumonia: serologic results of a prospective, population-based study Pediatr Infect Dis J 17 986 991 10.1097/00006454- 199811000-00004 1:STN:280:DyaK1M%2FmsFagsw%3D%3D 9849979
4. B Kashyap S Kumar GR Sethi BC Das SR Saigal 2008 Comparison of PCR, culture & serological tests for the diagnosis of Mycoplasma pneumoniae in community-acquired lower respiratory tract infections in children Indian J Med Res 128 134 139 1:CAS:528:DC%2BD1cXhtl2gtrnK 19001676
5. K McIntosh 2002 Community-acquired pneumonia in children N Engl J Med 346 429 437 10.1056/NEJMra011994 11832532 (Pubitemid 34437699)
6. M Morozumi K Hasegawa N Chiba S Iwata N Kawamura H Kuroki, et al. 2004 Application of PCR for Mycoplasma pneumoniae detection in children with community-acquired pneumonia J Infect Chemother 10 274 279 10.1007/s10156-004- 0338-y 1:CAS:528:DC%2BD2cXps1Onu7k%3D 16163461 (Pubitemid 40064208)
7. E Nakayama K Hasegawa M Morozumi R Kobayashi N Chiba T Iitsuka, et al. 2007 Rapid optimization of antimicrobial chemotherapy given to pediatric patients with community-acquired pneumonia using PCR techniques with serology and standard culture J Infect Chemother 13 305 313 10.1007/s10156-007-0535-6 1:CAS:528:DC%2BD2sXht1Glu73F 17982719 (Pubitemid 350059915)
8. F Oguz E Unuvar D Aydin K Yilmaz M Sidal 2002 Frequency of Mycoplasma pneumoniae among atypical pneumonia of childhood Turk J Pediatr 44 283 288 12458801
9. A Defilippi M Silvestri A Tacchella R Giacchino G Melioli E Di Marco, et al. 2008 Epidemiology and clinical features of Mycoplasma pneumoniae infection in children Respir Med 102 1762 1768 10.1016/j.rmed.2008.06.022 18703327
10. LS Howard M Sillis MC Pasteur AV Kamath BD Harrison 2005 Microbiological profile of community-acquired pneumonia in adults over the last 20 years J Infect 50 107 113 10.1016/j.jinf.2004.05.003 1:STN:280:DC%2BD2M%2FktVOhug%3D%3D 15667910
11. T Ishida T Hashimoto M Arita I Ito M Osawa 1998 Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan Chest 114 1588 1593 10.1378/chest.114.6.1588 1:STN:280: DyaK1M%2FoslWqug%3D%3D 9872193
12. MA Martínez M Ruiz E Zunino V Luchsinger LF Avendaño 2008 Detection of Mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology J Med Microbiol 57 1491 1495 10.1099/jmm.0.2008/003814-0 19018018
13. N Miyashita K Ouchi K Kawasaki K Oda Y Kawai H Shimizu, et al. 2008 Mycoplasma pneumoniae pneumonia in the elderly Med Sci Monit 14 387 391
14. A Porath F Schlaeffer D Lieberman 1997 The epidemiology of community-acquired pneumonia among hospitalized adults J Infect 34 41 48 10.1016/S0163-4453(97)80008-4 1:STN:280:DyaK2s7pslSjtQ%3D%3D 9120323 (Pubitemid 27110413)
15. T Takahashi M Morozumi N Chiba R Asami T Okada SY Murayama, et al. 2009 Prolonged Mycoplasma pneumoniae infection in an elderly patient with community-acquired pneumonia J Infect Chemother 15 243 247 10.1007/s10156-009- 0692-x 19688244
16. M Abele-Horn U Busch H Nitschko E Jacobs R Bax F Pfaff, et al. 1998 Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae J Clin Microbiol 36 548 551 1:CAS:528:DyaK1cXnsFGhsQ%3D%3D 9466774
17. JW Dorjgo-Zetsma RP Verkooyen HP Van Helden H Van der Nat JM Van den Bosch 2001 Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring Hospitalization J Clin Microbiol 39 1184 1186 10.1128/JCM.39.3.1184-1186.2001 (Pubitemid 32209749)
18. JW Dorigo-Zetsma SA Zaat PM Wertheim-van Dillen L Spanjaard J Rijntjes G van Waveren, et al. 1999 Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children J Clin Microbiol 37 14 17 1:CAS:528:DyaK1MXks1Omuw%3D%3D 9854056
19. D Hardegger D Nadal W Bossart M Altwegg F Dutly 2000 Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR J Microbiol Methods 41 45 51 10.1016/S0167-7012(00)00135-4 1:CAS:528:DC%2BD3cXjvFKntro%3D 10856776 (Pubitemid 30345719)
20. M Ieven D Ursi H Van Bever W Quint HG Niesters H Goossens 1996 Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients J Infect Dis 173 1445 1452 1:STN:280:DyaK283hslOnsQ%3D%3D 8648218
21. M Khanna J Fan K Pehler-Harrington C Waters P Douglass J Stallock, et al. 2005 The pneumoplex assays, a multiplex PCR-enzyme hybridization assay that allows simultaneous detection of five organisms, Mycoplasma pneumoniae, Chlamydia (Chlamydophila) pneumoniae, Legionella pneumophila, Legionella micdadei, and Bordetella pertussis, and its real-time counterpart J Clin Microbiol 43 565 571 10.1128/JCM.43.2.565-571.2005 1:CAS:528: DC%2BD2MXit1aru7g%3D 15695646 (Pubitemid 40256001)
22. M Morozumi E Nakayama S Iwata Y Aoki K Hasegawa R Kobayashi, et al. 2006 Simultaneous detection of pathogens in clinical samples from patients with community-acquired pneumonia by real-time PCR with pathogen-specific molecular beacon probes J Clin Microbiol 44 1440 1446 10.1128/JCM.44.4.1440-1446.2006 1:CAS:528:DC%2BD28XkvVamtro%3D 16597874
23. D Nadala W Bossart F Zucol F Steiner C Berger U Lips, et al. 2001 Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR Diagn Microbiol Infect Dis 39 15 19 10.1016/S0732-8893(00)00216-9 1:CAS:528:DC%2BD3MXhtFeis70%3D 11173186 (Pubitemid 32149950)
24. S Otomo J Yamamura E Hayashi T Nakamura H Kakinuma Y Nakamoto, et al. 2008 Analysis of children with Chlamydophila (Chlamydia) pneumoniae and Mycoplasma pneumoniae respiratoryinfections by real-time PCR assay and serological tests APMIS 116 477 483 10.1111/j.1600-0463.2008.00973.x 1:CAS:528:DC%2BD1cXpslKisbw%3D 18754321
25. D Pitcher VJ Chalker C Sheppard RC George TG Harrison 2006 Real-time detection of Mycoplasma pneumoniae in respiratory samples with an internal processing control J Med Microbiol 55 149 155 10.1099/jmm.0.46281-0 1:CAS:528:DC%2BD28Xhslagtbc%3D 16434706 (Pubitemid 43201741)
26. KE Templeton SA Scheltinga AW Graffelman JM van Schie JW Crielaard P Sillekens, et al. 2003 Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae J Clin Microbiol 41 4366 4371 10.1128/JCM.41.9.4366-4371.2003 1:CAS:528:DC%2BD3sXnvFaqur0%3D 12958270 (Pubitemid 37099708)
27. JH Tjhie FJ van Kuppeveld R Roosendaal WJ Melchers R Gordijn DM MacLaren, et al. 1994 Direct PCR enables detection of Mycoplasma pneumoniae in patients with respiratory tract infections J Clin Microbiol 32 11 16 1:CAS:528: DyaK2cXpslejtg%3D%3D 7510308
28. M Welti K Jaton M Altwegg R Sahli A Wenger J Bille 2003 Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions Diagn Microbiol Infect Dis 45 85 95 10.1016/S0732-8893(02)00484-4 1:CAS:528:DC%2BD3sXhsVansrY%3D 12614979 (Pubitemid 36263020)
29. D Felmingham MJ Robbins M Sanghrajka A Leakey GL Ridgway 1991 The in vitro activity of some 14-, 15- and 16-membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum Drugs Exp Clin Res 17 91 99 1:CAS:528:DyaK3MXlsFCrtb0%3D 1650694
30. K Ishida M Kaku K Irifune R Mizukane H Takemura R Yoshida, et al. 1994 In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae Antimicrob Agents Chemother 38 790 798 1:CAS:528:DyaK2cXis1SltLY%3D 8031048 (Pubitemid 24114020)
31. M Morozumi K Hasegawa R Kobayashi N Inoue S Iwata H Kuroki, et al. 2005 Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation Antimicrob Agents Chemother 49 2302 2306 10.1128/AAC.49.6.2302-2306. 2005 1:CAS:528:DC%2BD2MXkvFCgsr0%3D 15917525 (Pubitemid 40734458)
32. KA Rennie ES Prasad WM Wenman 1994 In vitro activity of dirithromycin, a new macrolide antibiotic, against Mycoplasma species Diagn Microbiol Infect Dis 20 57 59 10.1016/0732-8893(94)90020-5 1:CAS:528:DyaK2MXivFSnu7c%3D 7867300 (Pubitemid 24361847)
33. KB Waites GH Cassell KC Canupp PB Fernandes 1988 In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones Antimicrob Agents Chemother 32 1500 1502 1:CAS:528:DyaL1MXitV2rtg%3D%3D 2973283
34. N Okazaki M Narita S Yamada K Izumikawa M Umetsu T Kenri, et al. 2001 Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro Microbiol Immunol 45 617 620 1:CAS:528:DC%2BD3MXmvFWgtL8%3D 11592636
35. N Okazaki H Ohya T Sasaki 2007 Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976-2006: emergence of macrolide-resistant strains Jpn J Infect Dis 60 325 326 17881881
36. M Morozumi S Iwata K Hasegawa N Chiba R Takayanagi K Matsubara, et al. 2008 Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia Antimicrob Agents Chemother 52 348 350 10.1128/AAC.00779-07 1:CAS:528:DC%2BD1cXkslemsQ%3D%3D 17954691
37. X Li TP Atkinson J Hagood C Makris LB Duffy KB Waites 2009 Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates Pediatr Infect Dis J 28 693 696 10.1097/INF.0b013e31819e3f7a 19633515
38. Y Liu X Ye H Zhang X Xu W Li D Zhu, et al. 2009 Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China Antimicrob Agents Chemother 53 2160 2162 10.1128/AAC.01684-08 1:CAS:528:DC%2BD1MXlvVGnsrY%3D 19273684
39. S Pereyre A Charron H Renaudin C Bébéar CM Bébéar 2007 First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years J Clin Microbiol 45 3534 3539 10.1128/JCM.01345-07 1:CAS:528:DC%2BD2sXhsVWrtLrO 17881549 (Pubitemid 350156844)
40. D Xin Z Mi X Han L Qin J Li T Wei, et al. 2009 Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China Antimicrob Agents Chemother 53 2158 2159 10.1128/AAC.01563-08 1:CAS:528:DC%2BD1MXlvVGnsrk%3D 19273685
41. BJ Wolff WL Thacker SB Schwartz JM Winchell 2008 Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis Antimicrob Agents Chemother 52 3542 3549 10.1128/AAC.00582-08 1:CAS:528:DC%2BD1cXht1SrtbnM 18644962
42. ER Alexander HM Foy GE Kenny RA Kronmal R McMahan ER Clarke, et al. 1966 Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group N Engl J Med 275 131 136 1:STN:280: DyaF287ltF2nsw%3D%3D 5938858
43. BW Eun NH Kim EH Choi HJ Lee 2008 Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period J Infect 56 326 331 10.1016/j.jinf.2008.02.018 18420275
44. DR Feikin JF Moroney DF Talkington WL Thacker JE Code LA Schwartz, et al. 1999 An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and adenovirus at a federal service training academy: new implications from an old scenario Clin Infect Dis 29 1545 1550 10.1086/313500 1:STN:280: DC%2BD3c%2Fltl2ntw%3D%3D 10585810 (Pubitemid 30022755)
45. GS Hauksdóttir T Jónsson V Sigurdardóttir A Löve 1998 Seroepidemiology of Mycoplasma pneumoniae infections in Iceland 1987-96 Scand J Infect Dis 30 177 180 10.1080/003655498750003591 9730307
46. K Lind MW Benzon JS Jensen WA Clyde Jr 1997 A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995 Eur J Epidemiol 13 581 586 10.1023/A:1007353121693 1:STN:280: DyaK2svgtlajsQ%3D%3D 9258572 (Pubitemid 27306179)
47. MF Beersma K Dirven AP van Dam KE Templeton EC Claas H Goossens 2005 Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard" J Clin Microbiol 43 2277 2285 10.1128/JCM.43.5.2277-2285.2005 1:CAS:528:DC%2BD2MXkvFOqsbY%3D 15872256 (Pubitemid 40656241)
48. M Narita T Togashi 2003 Evaluation of a rapid IgM antibody detection kit for diagnosis of Mycoplasma pneumoniae infection during childhood Kansenshogaku Zasshi 77 310 315 12806926
49. F Daxboeck K Kircher R Krause H Heinzl C Wenisch G Stanek 2002 Effect of age on antibody titer to Mycoplasma pneumoniae Scand J Infect Dis 34 577 579 10.1080/00365540110089836 12238572 (Pubitemid 35012339)
50. M Sillis 1990 The limitations of IgM assays in the serological diagnosis of Mycoplasma pneumoniae infections J Med Microbiol 33 253 258 10.1099/00222615-33-4-253 1:STN:280:DyaK3M%2FotVWhtw%3D%3D 2124271
51. LH Hansen P Mauvais S Douthwaite 1999 The macrolide-ketolide antibiotic binding site is formed by structures in domain II and V of 23S ribosomal RNA Mol Microbiol 31 623 631 10.1046/j.1365-2958.1999.01202.x 1:CAS:528: DyaK1MXhtFygsr0%3D 10027978 (Pubitemid 29046103)
52. J Poehlsgaard S Douthwaite 2003 Macrolide antibiotic interaction and resistance on the bacterial ribosome Curr Opin Investig Drugs 4 140 148 1:CAS:528:DC%2BD3sXjt1Wkt7w%3D 12669373
53. B Vester S Douthwaite 2001 Macrolide resistance conferred by base substitutions in 23S rRNA Antimicrob Agents Chemother 45 1 12 10.1128/AAC.45.1.1-12.2001 1:CAS:528:DC%2BD3MXhsFCrtQ%3D%3D 11120937 (Pubitemid 32039086)
54. Bryskier A, Agouridas C, Chantot JF. Ketolides: new semisynthetic 14-membered-ring macrolides. In: Zinner SH, Young LS, Acar JF, Neu HC, editors. Expanding indications for the new macrolides, azalides, and streptogramins. New York: Marcel Dekker Inc; 1997. p. 39-50.
55. TS Lucier K Heitzman SK Liu PC Hu 1995 Trasition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae Antimicrob Agents Chemother 39 2770 2773 1:CAS:528:DyaK2MXps1Orsbc%3D 8593017
56. S Pereyre C Guyot H Renaudin A Charron C Bébéar CM Bébéar 2004 In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae Antimicrob Agents Chemother 48 460 465 10.1128/AAC.48.2.460-465.2004 1:CAS:528: DC%2BD2cXhtFGlsLo%3D 14742195 (Pubitemid 38141702)
57. K Ubukata S Iwata K Sunakawa 2003 In vitro activities of new ketolide, telithromycin, and eight other macrolide antibiotics against Strptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance J Infect Chemother 9 221 226 10.1007/s10156-003-0258-2 1:CAS:528:DC%2BD3sXnsF2ntLk%3D 14513389 (Pubitemid 37288285)
58. V Cattoir L Merabet P Legrand CJ Soussy R Leclercq 2007 Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia J Antimicrob Chemother 59 1010 1012 10.1093/jac/dkm041 1:CAS:528: DC%2BD2sXmt1els7w%3D 17434877 (Pubitemid 47073376)
59. RR Reinert A Al-Lahham 2005 Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22 Antimicrob Agents Chemother 49 3011 3013 10.1128/AAC.49.7.3011-3013.2005 1:CAS:528:DC%2BD2MXlvFSltr8%3D 15980387 (Pubitemid 40917629)
60. CM Bébéar S Pereyre 2005 Mechanisms of drug resistance in Mycoplasma pneumoniae Curr Drug Targets Infect Disord 5 263 271 10.2174/1568005054880109 16181145 (Pubitemid 41448372)
61. D Gruson S Pereyre H Renaudin A Charron C Bébéar CM Bébéar 2005 In vitro development of resistance to six and four FQ in Mycoplasma pneumoniae and, respectively Antimicrob Agents Chemother 49 1190 1193 10.1128/AAC.49.3.1190-1193.2005 1:CAS:528:DC%2BD2MXit12lsrw%3D 15728924 (Pubitemid 40327745)
62. MM Anokhina A Barta KH Nierhaus VA Spiridonova AM Kopylov 2004 Mapping of the second tetracycline binding site on the ribosomal small subunit of E. coli Nucleic Acids Res 32 2594 2597 10.1093/nar/gkh583 1:CAS:528:DC%2BD2cXktVahsLc%3D 15141029 (Pubitemid 38854812)
63. DE Brodersen WM Clemons Jr AP Carter RJ Morgan-Warren BT Wimberly V Ramakrishnan 2000 The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit Cell 103 1143 1154 10.1016/S0092-8674(00)00216-6 1:CAS:528:DC%2BD3MXit1aisg%3D%3D 11163189 (Pubitemid 32037400)
64. MC Roberts LA Koutsky KK Holmes DJ LeBlanc GE Kenny 1985 Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences Antimicrob Agents Chemother 28 141 143 1:CAS:528:DyaL2MXks1Gru7s%3D 2994555
65. M Matsuoka M Narita N Okazaki H Ohya T Yamazaki K Ouchi, et al. 2004 Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan Antimicrob Agents Chemother 48 4624 4630 10.1128/AAC.48.12.4624-4630.2004 1:CAS:528:DC%2BD2cXhtVKmtrbJ 15561835 (Pubitemid 39577663)
66. R Isozumi H Yoshimine M Morozumi K Ubukata K Ariyoshi 2009 Adult case of community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae Respirology 14 8 1206 1208 10.1111/j.1440-1843.2009.01619.x 19732389
67. O Peuchant A Ménard H Renaudin M Morozumi K Ubukata CM Bébéar, et al. 2009 Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis J Antimicrob Chemother 64 52 58 10.1093/jac/dkp160 1:CAS:528:DC%2BD1MXntlGgsL8%3D 19429926
68. A Cousin-Allery A Charron BD Barbeyrac G Fremy JS Jensen H Renaudin, et al. 2000 Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis. Application to French and Danish isolates Epidemiol Infect 124 103 111 10.1017/S0950268899003313 1:CAS:528: DC%2BD3cXisFSmu7o%3D 10722137 (Pubitemid 30103416)
69. K Numazaki M Umetsu N Adachi 2003 Mycoplasma pneumoniae infection and its genotypical characterization in children of Hokkaido, Japan In Vivo 17 421 424 14598604
70. SB Schwartz KA Thurman SL Mitchell BJ Wolff JM Winchell 2009 Genotyping of Mycoplasma pneumoniae isolates using real-time PCR and high-resolution melt analysis Clin Microbiol Infect 15 756 762 10.1111/j.1469-0691.2009.02814.x 1:CAS:528:DC%2BD1MXht1WhtLzL 19392882
71. S Suzuki T Yamazaki M Narita N Okazaki I Suzuki T Andoh, et al. 2006 Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae Antimicrob Agents Chemother 50 709 712 10.1128/AAC.50.2.709-712.2006 1:CAS:528: DC%2BD28XhsFegur0%3D 16436730 (Pubitemid 43190986)
72. K Matsubara M Morozumi T Okada T Matsushima O Komiyama M Shoji, et al. 2009 A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients J Infect Chemother 15 6 380 383 10.1007/s10156-009-0715-7 20012728
73. FW Denny WA Clyde Jr WP Glezen 1971 Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control J Infect Dis. 123 74 92 1:STN:280:DyaE3M7gvFGnug%3D%3D 5100980
74. CB Smith WT Friedewald RM Chanock 1967 Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy N Engl J Med 276 1172 1175 1:STN:280:DyaF2s7jsFWluw%3D%3D 6023234
75. YJ Lu TH Chen LH Lin CM Shen CH Huang 2008 Macrolide use shortens fever duration in Mycoplasma pneumoniae infection in children: a 2-year experience J Microbiol Immunol Infect 41 307 310 1:CAS:528:DC%2BD1MXht1yrt78%3D 18787737
76. SD John J Ramanathan LE Swischuk 2001 Spectrum of clinical and radiographic findings in pediatric mycoplasma pneumonia Radiographics 21 121 131 1:STN:280:DC%2BD3MzgtFequw%3D%3D 11158648
77. Wieslander A, Boyer MJ, Wroblewski H. Membrane protein structure. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, editors. Mycoplasmas: molecular biology, pathogenesis. Washington: American Society for Microbiology; 1992. p. 93-112.
78. K Chmura X Bai M Nakamura P Kandasamy M McGibney K Kuronuma, et al. 2008 Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells Am J Physiol Lung Cell Mol Physiol 295 220 230 10.1152/ajplung.90204.2008
79. SA Broaders WC Hooper DJ Phillips DF Talkington 2006 Mycoplasma pneumoniae subtype-independent induction of proinflammatory cytokines in THP-1 cells Microb Pathog 40 286 292 10.1016/j.micpath.2006.03.002 1:CAS:528:DC%2BD28XltFOksb4%3D 16678382 (Pubitemid 43786310)
80. R Chaudhry AK Varshney P Malhotra 2007 Adhesion proteins of Mycoplasma pneumoniae Front Biosci 12 690 699 10.2741/2093 1:CAS:528:DC%2BD28Xht1WgsLvE 17127329 (Pubitemid 46852814)
81. G Layh-Schmitt A Podtelejnikov M Mann 2000 Proteins complexed to the P1 adhesin of Mycoplasma pneumoniae Microbiology 146 741 747 1:CAS:528: DC%2BD3cXitVans7k%3D 10746778
82. S Seto M Miyata 2003 Attachment organelle formation represented by localization of cytadherence proteins and formation of the electron-dense core in wild-type and mutant strains of Mycoplasma pneumoniae J Bacteriol 185 1082 1091 10.1128/JB.185.3.1082-1091.2003 1:CAS:528:DC%2BD3sXosF2luw%3D%3D 12533484 (Pubitemid 36139467)
83. KB Waites DF Talkington 2004 Mycoplasma pneumoniae and its role as a human pathogen Clin Microbiol Rev 17 697 728 10.1128/CMR.17.4.697-728.2004 1:CAS:528:DC%2BD2cXhtVSht7jK 15489344 (Pubitemid 39372513)
84. J Yang WC Hooper DJ Phillips DF Talkington 2002 Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae Infect Immun 70 3649 3655 10.1128/IAI.70.7.3649-3655.2002 1:CAS:528:DC%2BD38XkvV2ksrk%3D 12065506 (Pubitemid 34666003)
85. J Yang WC Hooper DJ Phillips DF Talkington 2004 Cytokines in Mycoplasma pneumoniae infections Cytokine Growth Factor Rev 15 157 168 10.1016/j.cytogfr. 2004.01.001 1:CAS:528:DC%2BD2cXjsVWmsr8%3D 15110799 (Pubitemid 38521251)
86. M Narita H Tanaka S Yamada S Abe T Ariga Y Sakiyama 2001 Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection Clin Diagn Lab Immunol 8 1028 1030 1:CAS:528: DC%2BD3MXnt1Sks74%3D 11527824
87. M Narita H Tanaka S Abe S Yamada M Kubota T Togashi 2000 Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon Clin Diagn Lab Immunol 7 909 914 1:CAS:528:DC%2BD3MXkt1OjtL0%3D 11063497
88. M Narita H Tanaka 2007 Cytokines involved in the severe manifestations of pulmonary diseases caused by Mycoplasma pneumoniae Pediatr Pulmonol 42 397 10.1002/ppul.20445 17330264 (Pubitemid 46608913)
89. H Tanaka M Narita S Teramoto T Saikai K Oashi T Igarashi, et al. 2002 Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults Chest 121 1493 1497 10.1378/chest.121.5.1493 1:CAS:528:DC%2BD38XksFGgtL8%3D 12006434 (Pubitemid 34499661)
90. S Abe H Nakamura S Inoue H Takeda H Saito S Kato, et al. 2000 Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells Am J Respir Cell Mol Biol 22 51 60 1:CAS:528:DC%2BD3cXntFKitw%3D%3D 10615065
91. B Beović B Bonac D Kese T Avsic-Zupanc S Kreft G Lesnicar, et al. 2003 Aetiology and clinical presentation of mild community-acquired bacterial pneumonia Eur J Clin Microbiol Infect Dis 22 584 591 10.1007/s10096-003-0997-0 13680399 (Pubitemid 37363536)
92. TJ Marrie 1998 Epidemiology of mild pneumonia Semin Respir Infect 13 3 7 1:STN:280:DyaK1c3gt1CksA%3D%3D 9543470
93. KB Waites 2003 New concepts of Mycoplasma pneumoniae infections in children Pediatr Pulmonol 36 267 278 10.1002/ppul.10346 12950038 (Pubitemid 37129765)
94. N Miyashita Y Obase K Ouchi K Kawasaki Y Kawai Y Kobashi, et al. 2007 Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit J Med Microbiol 56 1625 1629 10.1099/jmm.0.47119-0 18033831 (Pubitemid 350276512)
95. DH Kim KY Lee MS Kim YS Youn JY Hwang JW Rhim, et al. 2009 Corticosteroid treatment in siblings affected with severe Mycoplasma pneumoniae pneumonia Infect Chemother 41 3 190 195 10.3947/ic.2009.41.3.190
96. C Tagliabue CM Salvatore C Techasaensiri A Mejias JP Torres K Katz AM Gomez S Esposito N Principi RD Hardy 2008 The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection J Infect Dis 198 1180 1188 10.1086/591915 1:CAS:528:DC%2BD1cXht1OmtrbK 18717637
97. M Radisic A Torn P Gutierrez HA Defranchi P Pardo 2000 Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment Clin Infect Dis 31 1507 1511 10.1086/317498 1:STN:280: DC%2BD3M3isVSnuw%3D%3D 11096025